Isoxsuprine Hydrochloride
| Catalog Number | : | CS-O-01667 |
|---|---|---|
| CAS Number | : | 579-56-6 |
| Status | : | Available for immediate dispatch |
| Category | : | API Standards |
| Purity | : | Not less than 95% |
| Molecular Weight | : | 337.84 mol/g |
| Molecular Formula | : | C₁₈H₂₄ClNO₃ |
| Industry | : | Forensic |
| List Price | Online Price | Size | Stock Status | Quantity | |
|---|---|---|---|---|---|
|
|||||
Shipping & Availability
| Status | : | Available for immediate dispatch |
|---|---|---|
| COA | : |
[Login Needed]
|
| MSDS | : |
[Login Needed]
|
| Hazardous Compound | : | No |
More Information
| Application | : | Isoxsuprine is a beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of perip |
|---|---|---|
| Payment mode | : | Credit / Debit / Purchase Order |
| Taxes | : | All prices are inclusive taxes |
| Refund Policy | : | 30 days money back guarantee |
| References | : | "Erkert; R,S, et al,: J, Vet, Pharmcol, Therap,; 25; 81 (2002); Giorgino; F,L, et al,: Arzneim, Forch,; 60; 415 (2010);" |
| Canonical SMILES | : | CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O.Cl |
| Isomeric SMILES | : | CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O.Cl |
| InChI | : | InChI=1S/C18H23NO3.ClH/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15;/h3-11,13-14,18-21H,12H2,1-2H3;1H |
| InchIKey | : | QVPSGVSNYPRFAS-UHFFFAOYSA-N |
| IUPAC Name | : | 4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol;hydrochloride |
| Exact Mass | : | 337.1444713 |
| Color | : | Crystals from water |
| Melting Point | : | 203-204 °C |
| Solubility | : | Soluble in ethanol |
| Hazard Class | : | Acute Tox. 4 (100%) |
| Description | : | Isoxsuprine hydrochloride is an alkylbenzene. |
| Disposal Methods | : | SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations. |
| EC Number | : | 209-443-6 |
| Antidoteand Emergency Treatment | : | /SRP:/ Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/ |
| Human Toxicity Excerpts | : | /HUMAN EXPOSURE STUDIES/ The developmental effects of isoxsuprine (I) were assessed in 20 very-low-birth-weight infants whose mothers had received intravenous I within 24 hr of delivery; 40 term and preterm infants served as controls. Infants exposed to I scored significantly lower than the term control group on the Mental Development Index. Neonates born after short term I therapy had outcomes at 2 yr of age similar to those of preterm infants without drug exposure. |
We also have the following compounds available for commercial bulk quantities
Clearsynth is a technology based, research driven enterprise with the world's largest inventory of Reference Standards & Research Chemicals. We aim to enable the research community in accelerated discovery via synthesis of complex and difficult to make compounds.
© 2022 Clearsynth - is a registered trademark and the marketing name for Clearsynth Labs and its subsidiaries worldwide. Copyright (c) 2010-2022 All rights reserved